Related Experiment Video
Updated: May 23, 2026
08:41
Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
Inflammasomes in carcinogenesis and anticancer immune responses
Laurence Zitvogel1, Oliver Kepp, Lorenzo Galluzzi
1Institut Gustave Roussy, Villejuif, France.
Nature Immunology
|March 21, 2012
Summary
Inflammasomes, crucial in cancer, can either eliminate tumors or promote their growth. Inhibiting inflammasomes and their products like IL-1β offers promising cancer treatment strategies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Inflammasomes, or caspase-1 activation complexes, play dual roles in cancer.
- They can induce programmed cell death in malignant precursors or support tumor growth.
Purpose of the Study:
- To explore the contrasting roles of inflammasomes in cancer.
- To discuss the therapeutic potential of inflammasome inhibitors in oncology.
Main Methods:
- Review of existing literature on inflammasome function in cancer.
- Analysis of the impact of inflammasome inhibition on tumor progression.
Main Results:
- Inflammasomes can promote or inhibit cancer depending on the cellular context.
- Inhibition of inflammasomes and their products (e.g., IL-1β, IL-18) affects carcinogenesis and tumor progression.
Conclusions:
- Inflammasomes are significant therapeutic targets for cancer treatment.
- Clinical applications of inflammasome inhibitors are expanding.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...